ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2
The performance of saliva specimens for the molecular detection of SARS-CoV-2 and a saliva pooling strategy as a diagnostic tool for epidemiological studies in current SARS-CoV-2 pandemic.
Evaluation of molecular point-of-care Xpert® Xpress SARS-CoV-2 detection implementation in resource limited settings (EXPERT-CoV2).
Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA).
SARS-CoV-2 seroprevalence among nursing home residents in March 2022 : brief communication on results of the scope-2 study (SARS-COV-2 seroprevalence)
Man-specific lectins from plants, fungi, algae and cyanobacteria, as potential blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) coronaviruses : biomedical perspectives
Diagnostic performance of the SARS-CoV-2 S1RBD IgG ELISA (immunodiagnostics) for the quantitative detection of SARS-CoV-2 antibodies on dried blood spots
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays
Coordinates of docked compounds from manuscript "Azapeptide activity-based probes for the SARS-CoV-2 main protease enable visualization of inhibition in infected cells"
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples